查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1323063

可生物降解支架的全球市场

Biodegradable Stents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到2030年全球可生物降解支架市场将达到272亿美元

在COVID-19之后的商业环境发生变化的情况下，生物可降解支架的全球市场规模预计2022年为24亿美元，预计到2030年将达到272亿美元，年复合成长率预计为35.2%。本报告分析的细分市场之一——冠状动脉支架，预计年复合成长率35%，到分析期结束时将达到 156 亿美元。鑑于大流行后持续的复苏，未来八年外周动脉支架细分市场的年复合成长率修正为 35.4%。

美国市场预计将增长6.266亿美元，中国年复合成长率为43.1%

预计2022年美国生物可降解支架市场规模将达到6.266亿美元。中国作为世界第二大经济体，预计到2030年市场规模将达到85亿美元，2022年至2030年的分析期间年复合成长率为43.1%。其他值得注意的地域市场包括日本和加拿大，预计 2022 年至 2030 年将分别增长 27.3% 和 31.2%。在欧洲，德国的复合年增长率预计为 29.3%。

受访企业示例

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co., Ltd.
  • Sahajanand Medical Technologies Pvt., Ltd.
  • Terumo Europe NV

目录

第1章调查方法

第2章执行摘要

  • 市场概况
  • 大公司
  • 市场趋势和促进因素
  • 全球市场预测

第3章市场分析

  • 我们
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 意大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳大利亚
  • 印度
  • 韩国
  • 亚太地区其他地区
  • 拉美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙特阿拉伯
  • 阿拉伯联合酋长国
  • 其他中东地区
  • 非洲

第4章竞争

简介目录
Product Code: MCP16208

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Biodegradable Stents Market to Reach $27.2 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Biodegradable Stents estimated at US$2.4 Billion in the year 2022, is projected to reach a revised size of US$27.2 Billion by 2030, growing at aCAGR of 35.2% over the period 2022-2030. Coronary Artery Stents, one of the segments analyzed in the report, is projected to record 35% CAGR and reach US$15.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Peripheral Artery Stents segment is readjusted to a revised 35.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $626.6 Million, While China is Forecast to Grow at 43.1% CAGR

The Biodegradable Stents market in the U.S. is estimated at US$626.6 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$8.5 Billion by the year 2030 trailing a CAGR of 43.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 27.3% and 31.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 29.3% CAGR.

Select Competitors (Total 46 Featured) -

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co., Ltd.
  • Sahajanand Medical Technologies Pvt., Ltd.
  • Terumo Europe NV

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Biodegradable Stents - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Biodegradable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Biodegradable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Coronary Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Coronary Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Peripheral Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Peripheral Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Polymer Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Polymer Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Metal Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Metal Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Cardiac Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 15: World Biodegradable Stents Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 16: USA Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 17: USA 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 18: USA Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 19: USA 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 21: USA 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 23: Canada 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 25: Canada 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Canada 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • JAPAN
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Japan 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 31: Japan 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Japan 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • CHINA
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 34: China Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 35: China 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 36: China Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 37: China 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: China 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • EUROPE
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 41: Europe 8-Year Perspective for Biodegradable Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 43: Europe 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Europe 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 47: Europe 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • FRANCE
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 48: France Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 49: France 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 50: France Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: France 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 52: France Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 53: France 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • GERMANY
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 54: Germany Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 55: Germany 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Germany 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 59: Germany 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • ITALY
    • TABLE 60: Italy Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 61: Italy 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Italy 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Italy 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • UNITED KINGDOM
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 66: UK Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 67: UK 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 68: UK Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: UK 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 70: UK Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 71: UK 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • SPAIN
    • TABLE 72: Spain Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 73: Spain 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Spain 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 76: Spain Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 77: Spain 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • RUSSIA
    • TABLE 78: Russia Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 79: Russia 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Russia 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 82: Russia Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Russia 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Rest of Europe 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 8-Year Perspective for Biodegradable Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2023 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Asia-Pacific 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 97: Asia-Pacific 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • AUSTRALIA
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 98: Australia Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Australia 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 100: Australia Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 101: Australia 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 102: Australia Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 103: Australia 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • INDIA
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 104: India Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: India 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 106: India Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 107: India 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 108: India Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 109: India 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • SOUTH KOREA
    • TABLE 110: South Korea Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: South Korea 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 112: South Korea Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 113: South Korea 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 114: South Korea Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 115: South Korea 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 116: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Rest of Asia-Pacific 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 118: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 119: Rest of Asia-Pacific 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 120: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • LATIN AMERICA
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 122: Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 123: Latin America 8-Year Perspective for Biodegradable Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2023 & 2030
    • TABLE 124: Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 125: Latin America 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 126: Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 127: Latin America 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Latin America 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • ARGENTINA
    • TABLE 130: Argentina Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 131: Argentina 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 132: Argentina Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 133: Argentina 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Argentina 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • BRAZIL
    • TABLE 136: Brazil Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 137: Brazil 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 138: Brazil Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 139: Brazil 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Brazil 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • MEXICO
    • TABLE 142: Mexico Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 143: Mexico 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 144: Mexico Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 145: Mexico 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Mexico 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 148: Rest of Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 149: Rest of Latin America 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 150: Rest of Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 151: Rest of Latin America 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • MIDDLE EAST
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 154: Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 155: Middle East 8-Year Perspective for Biodegradable Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2023 & 2030
    • TABLE 156: Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 157: Middle East 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Middle East 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 160: Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 161: Middle East 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • IRAN
    • TABLE 162: Iran Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 163: Iran 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 164: Iran Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Iran 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 166: Iran Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 167: Iran 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • ISRAEL
    • TABLE 168: Israel Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 169: Israel 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 170: Israel Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Israel 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 172: Israel Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 173: Israel 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • SAUDI ARABIA
    • TABLE 174: Saudi Arabia Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 175: Saudi Arabia 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 176: Saudi Arabia Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Saudi Arabia 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 178: Saudi Arabia Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 179: Saudi Arabia 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 180: UAE Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 181: UAE 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 182: UAE Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 183: UAE 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 184: UAE Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 185: UAE 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 186: Rest of Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 187: Rest of Middle East 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 188: Rest of Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Rest of Middle East 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 190: Rest of Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 191: Rest of Middle East 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030
  • AFRICA
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 192: Africa Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 193: Africa 8-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2023 & 2030
    • TABLE 194: Africa Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Africa 8-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2023 & 2030
    • TABLE 196: Africa Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 197: Africa 8-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2023 & 2030

IV. COMPETITION